Baseline patient characteristics of patients with ID
| Characteristics . | Resolved, n (%) . | Persistent, n (%) . |
|---|---|---|
| 5485 (100) | 7599 (100) | |
| Sex | ||
| Female | 4436 (80.9) | 6889 (90.7) |
| Male | 1049 (19.1) | 710 (9.3) |
| Age, y | ||
| 18-39 | 1540 (28.1) | 3511 (46.2) |
| 40-59 | 2291 (41.8) | 2891 (38.0) |
| ≥60 | 1654 (30.1) | 1297 (15.8) |
| Race/ethnicity | ||
| White | 4611 (84.1) | 5765 (75.9) |
| Black | 553 (10.0) | 1218 (16.0) |
| Asian | 218 (4.0) | 455 (6.0) |
| Other/not specified | 103 (1.9) | 161 (2.1) |
| Insurance | ||
| Medicare | 1275 (23.2) | 949 (12.5) |
| Private insurance | 3123 (56.9) | 4473 (58.9) |
| Medicaid/other public | 789 (14.4) | 1362 (17.9) |
| Uninsured | 298 (5.5) | 815 (10.7) |
| Medication type | ||
| Oral only | 2488 (45.4) | 4625 (60.8) |
| IV only | 390 (7.1) | 133 (1.8) |
| Both | 1766 (32.2) | 751 (9.9) |
| Neither | 841 (15.3) | 2090 (27.5) |
| Characteristics . | Resolved, n (%) . | Persistent, n (%) . |
|---|---|---|
| 5485 (100) | 7599 (100) | |
| Sex | ||
| Female | 4436 (80.9) | 6889 (90.7) |
| Male | 1049 (19.1) | 710 (9.3) |
| Age, y | ||
| 18-39 | 1540 (28.1) | 3511 (46.2) |
| 40-59 | 2291 (41.8) | 2891 (38.0) |
| ≥60 | 1654 (30.1) | 1297 (15.8) |
| Race/ethnicity | ||
| White | 4611 (84.1) | 5765 (75.9) |
| Black | 553 (10.0) | 1218 (16.0) |
| Asian | 218 (4.0) | 455 (6.0) |
| Other/not specified | 103 (1.9) | 161 (2.1) |
| Insurance | ||
| Medicare | 1275 (23.2) | 949 (12.5) |
| Private insurance | 3123 (56.9) | 4473 (58.9) |
| Medicaid/other public | 789 (14.4) | 1362 (17.9) |
| Uninsured | 298 (5.5) | 815 (10.7) |
| Medication type | ||
| Oral only | 2488 (45.4) | 4625 (60.8) |
| IV only | 390 (7.1) | 133 (1.8) |
| Both | 1766 (32.2) | 751 (9.9) |
| Neither | 841 (15.3) | 2090 (27.5) |